Elevance Health Inc.
ELV | NYSE
$407.29
-$3.66 (-0.89%)
Sep 21, 2026, 12:49 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 199.13B | 176.81B | 171.34B | 156.6B | 138.64B | 121.87B |
Cost of Revenue | 148.22B | 127.57B | 124.33B | 116.64B | 102.65B | 88.05B |
Gross Profit | 50.9B | 49.24B | 47.01B | 39.95B | 35.99B | 33.82B |
Operating Income | 8.11B | 8.89B | 8.75B | 8.45B | 8.95B | 7.71B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 6.71B | 7.9B | 7.72B | 7.6B | 7.93B | 6.24B |
Net Income | 5.66B | 5.98B | 5.99B | 5.89B | 6.1B | 4.57B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 42.79B | 40.36B | 38.27B | 31.5B | 27.05B | 26.11B |
Operating Expenses | 42.79B | 40.36B | 38.27B | 31.5B | 27.05B | 26.11B |
Interest Expense | 1.4B | 1.19B | 1.03B | 851M | 798M | 784M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 191.01B | 167.92B | 162.6B | 148.14B | 129.69B | 114.16B |
Income Tax Expense | 1.05B | 1.93B | 1.72B | 1.71B | 1.83B | 1.67B |
Shares Outstanding (Basic) | 221.8M | 232.87M | 233.07M | 240M | 243.8M | 250.8M |
Shares Outstanding (Diluted) | 221.8M | 232.9M | 237.4M | 242.8M | 246.8M | 254.3M |
EPS (Basic) | 25.18 | 25.81 | 25.38 | 24.56 | 25.25 | 18.23 |
EPS (Diluted) | 25.12 | 25.68 | 25.22 | 24.28 | 24.73 | 17.98 |
EBITDA | 9.66B | 10.48B | 10.49B | 10.13B | 10.03B | 8.18B |
EBIT | 8.11B | 9.09B | 8.75B | 8.45B | 8.72B | 7.02B |
Depreciation & Amortization | 1.55B | 1.39B | 1.75B | 1.68B | 1.3B | 1.15B |
Add to Watchlist
Select watchlists to add or remove ELV